Ureteral Stents Market Analysis Report By Material, By Application, By Region And Segment Forecasts From 2020 To 2027

Industry Insights

The global ureteral stents market size was worth USD 422.9 million in 2019. The market is anticipated to register a 7.0% CAGR over the forecast duration, 2020 to 2027. The rise in the number of kidney and urological disorders coupled with the adoption of advanced stents for effective urological procedures is driving the market growth. Ureteral stents are a thin hollow tube that is used to treat urine blockage. They are used to treat urinary incontinence and kidney stones. Without causing any obstruction to the ureter, these stents enable the passage of residuals. Any form of kidney and urological disorder require ureteral stents for proper healing.

In addition, prostate cancer and any tumors in the ureter require ureteral stents. As estimated by the American Cancer Society, in 2020, there would be 191,930 men with prostate cancer. Therefore, the rise in the number of prostate cancer has propelled the demand for this device. Further, increasing occurrence of urinary incontinence and urolithiasis owing to poor diet would also drive the product demand over the forecast duration. As per a study by the National Center for Biotechnology Information (NCBI), nearly 12.0% of Indian populations have urolithiasis and nearly 50% of them suffer a loss of kidney function.

The rise in the cases of kidney transplant has positively affected the ureteral stent market growth. As per the National Kidney Foundation (NKF) estimates, there are 121,678 people who require organ transplants in 2016, of which, 100,791 are waiting for kidney transplants. Further, more than 3,000 people are added to this list every month. A ureteral stent is placed inside the patient's body during a kidney transplant for a few days and it is removed only when the newly transplanted kidney adapts to normal functioning. Therefore, increasing renal transplants and growing concern about renal dysfunction are supplementing the product demand.

Countries like Canada and the United States have witnessed a rise in the number of urological disorders owing to the increasing number of kidney disorders. One in every three American adults is vulnerable to kidney disorders and it is ranked as the ninth leading cause of death in the country. Thus, the increasing number of renal transplant is anticipated to surge the demand for ureteral stents in the country. In addition, sophisticated healthcare infrastructure and favorable reimbursement policies are further estimated to drive the product demand in the country.

Material Insights

Based on the material, the polymer ureteral stents category acquired the highest share of over 64.0% in the market in 2019. Further, the segment is anticipated to witness a 7.2% CAGR from 2020 to 2027. This segment is further bifurcated into hybrid stents, polyurethane stents, and silicone stents. The growing adoption of these devices by both patients and physicians is driving the segment growth. Various benefits such as biocompatibility and flexibility make the polymer suitable material for the production of stents.

In addition, polymer-made ureteral stents are ideal for the minimally invasive procedure and provide quick healing, thereby, reducing hospital stay. Owing to this factor, the demand for a polymer made stents is gaining traction among physicians. In addition, owing to the several advantages, regulatory agencies are also recommending polymer stents for various applications, which in turn, leading to the segment growth.

Application Insights

Depending on the application, the kidney stones category held the highest share of more than 36.0% in the ureteral stents market in 2019. Growing prevalence of urolithiasis owing to a sedentary lifestyle and dietary habits is attributing to the growth of this segment. As reported by NCBI, there are almost 600,000 cases of urinary stones in the United States in 2018. Ureterorenoscopy and Ureteroscopy need ureteral stent for kidney treatment, which in turn, is driving the segment growth.

The other segment is anticipated to register the maximum growth with a 7.8% CAGR over the forecast duration. Rising cases of prostate cancer, ureter narrowing, ureteral stricture, and Benign Prostatic Hyperplasia (BPH) are attributing the growth of this segment. These disorders are increasingly present among males. The ureteral stents are needed to treat these conditions.

Regional Insights

In 2019, North America held the highest share in the ureteral stents market with a 33.0% share in the revenue. Further, the region is anticipated to register considerable growth over the next few years. Growing cases of kidney and urological disorders owing to sedentary lifestyles are primarily attributing to the growth of the region. In addition, the presence of several leading players like Coloplast, Medline Industries and Boston Scientific Corporation is further driving regional growth.

On the other hand, Asia Pacific is projected to register the maximum growth with a 7.5% CAGR from 2020 to 2027. The increasing number of kidney disorders. Growing urological procedures and improvement in healthcare infrastructure are attributing to the growth of the Asia Pacific region. In addition, countries such as India, China and Japan are witnessing a surge in medical tourism, which, in turn, is further estimated to contribute to the regional growth. Factors such as increasing spending on healthcare, improvement in reimbursement policies, and low-cost production of ureteral stents are also attributing to the growth of the region.

COVID-19 Impact Analysis

The market has been negatively affected owing to the outbreak of COVID-19. In addition, supply chain disruption of raw material such as polymer and metallic materials has further delayed the production of ureteral stents. The pandemic has put an immense burden on healthcare. Amid rising patient counts in hospitals and a shortage of healthcare professionals, a large number of patients with kidney and urological disorders are waiting to get access to proper medical care. This trend is estimated to continue over the next few years. However, medical professionals and healthcare facilities have introduced telehealth services to assist the patient.

Ureteral Stents Market Share Insights

Leading market players have increased their spending on research and development to introduce technically advanced products. For example, University Hospitals Cleveland Medical Center has been working on RELIEF Ureteral Stent. This product is still in the clinical trial and is estimated to provide improved patient care.

In addition, major companies are focusing on merger & acquisitions and collaboration to strengthen their market reach. For example, Merit Medical Systems made an acquisition of Brightwater Medical, Inc. in mid-2019. With this acquisition, the former company will align the latter company’s product in its product portfolio. Some of the leading market players are Cook Medical, Medline Industries, Olympus Corporation, BD, Teleflex Incorporated, and Boston Scientific Corporation among others.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Million Insights has segmented the global ureteral stents market report based on material, application, and region:

• Material Outlook (Revenue, USD Million, 2016 - 2027)
    • Metallic Ureteral Stents
    • Polymer Ureteral Stents
        • Silicone Stents
       • Polyurethane Stents
       • Hybrid Stents

• Application Outlook (Revenue, USD Million, 2016 - 2027)
    • Kidney Stones
    • Kidney Transplantation
    • Tumors
    • Urinary Incontinence
    • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
       • The U.S.
       • Canada
    • Europe
       • Germany
       • The U.K.
       • France
       • Italy
       • Spain
    • Asia Pacific
       • Japan
       • China
       • India
       • Australia
       • South Korea
    • Latin America
       • Brazil
       • Mexico
       • Argentina
       • Colombia
    • The Middle East and Africa (MEA)
       • South Africa
       • Saudi Arabia
       • UAE